LLY

1,011.28

-2.39%↓

JNJ

202.37

-1.51%↓

ABBV

228.23

-0.06%↓

UNH

334.44

-0.4%↓

AZN

90.21

-0.67%↓

LLY

1,011.28

-2.39%↓

JNJ

202.37

-1.51%↓

ABBV

228.23

-0.06%↓

UNH

334.44

-0.4%↓

AZN

90.21

-0.67%↓

LLY

1,011.28

-2.39%↓

JNJ

202.37

-1.51%↓

ABBV

228.23

-0.06%↓

UNH

334.44

-0.4%↓

AZN

90.21

-0.67%↓

LLY

1,011.28

-2.39%↓

JNJ

202.37

-1.51%↓

ABBV

228.23

-0.06%↓

UNH

334.44

-0.4%↓

AZN

90.21

-0.67%↓

LLY

1,011.28

-2.39%↓

JNJ

202.37

-1.51%↓

ABBV

228.23

-0.06%↓

UNH

334.44

-0.4%↓

AZN

90.21

-0.67%↓

Search

Stevanato Group SpA

Abrir

SetorSaúde

23.48 3.57

Visão Geral

Variação de preço das ações

24h

Atual

Mín

22.49

Máximo

23.35

Indicadores-chave

By Trading Economics

Rendimento

10M

49M

Vendas

23M

303M

P/E

Médio do Setor

38.271

80.03

EPS

0.162

Rendimento de Dividendos

0.23

Margem de lucro

16.205

Funcionários

5,521

EBITDA

10M

73M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+22.17% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.23%

2.29%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-573M

6.2B

Abertura anterior

19.91

Fecho anterior

23.48

Sentimento de Notícias

By Acuity

50%

50%

167 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Stevanato Group SpA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de dez. de 2025, 23:21 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

EQB to Buy Loblaw Unit PC Financial for About $573.5 Million -- Update

3 de dez. de 2025, 23:14 UTC

Aquisições, Fusões, Aquisições de Empresas

EQB to Buy PC Financial From Loblaw for About $573.5 Million

3 de dez. de 2025, 22:01 UTC

Grandes Movimentos do Mercado

Costco Wholesale Reports Higher Monthly Sales

3 de dez. de 2025, 21:38 UTC

Ganhos

Salesforce Raises Revenue Forecast as Agentforce Sales Top $500 Million

3 de dez. de 2025, 23:59 UTC

Conversa de Mercado

Australian Coal Prices Seen Having Recovered Well -- Market Talk

3 de dez. de 2025, 23:49 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

3 de dez. de 2025, 23:49 UTC

Conversa de Mercado

HSBC Chair Appointment Unlikely to Have Material Operational Impact -- Market Talk

3 de dez. de 2025, 23:49 UTC

Conversa de Mercado

Nikkei May Decline Amid Caution Over U.S. Labor Market -- Market Talk

3 de dez. de 2025, 23:13 UTC

Conversa de Mercado

Australian Treasurer Says Economy Not On Drip of Govt Spending -- Market Talk

3 de dez. de 2025, 23:10 UTC

Ganhos

Salesforce Raises Forecast as Agentforce Sales Top $500M -- Update

3 de dez. de 2025, 23:08 UTC

Conversa de Mercado

Goodman's New Bull Sees Profit Upgrade on Cards -- Market Talk

3 de dez. de 2025, 23:06 UTC

Aquisições, Fusões, Aquisições de Empresas

EQB to Buy Loblaw Unit PC Financial for About $573.5M -- Update

3 de dez. de 2025, 22:59 UTC

Aquisições, Fusões, Aquisições de Empresas

EQB to Buy PC Financial From Loblaw for About $573.5M

3 de dez. de 2025, 22:45 UTC

Conversa de Mercado

WiseTech Investor Day Increases Bull's Confidence -- Market Talk

3 de dez. de 2025, 22:20 UTC

Ganhos

Salesforce CEO: 9,500 of 18,500 Total Closed Agentforce Deals Are Paid

3 de dez. de 2025, 22:19 UTC

Ganhos

Salesforce CEO: Six Out of 10 Biggest Deals in 3Q Came from Agentforce

3 de dez. de 2025, 22:17 UTC

Ganhos

Salesforce Working to Add Voice to Agentforce, CEO Says

3 de dez. de 2025, 22:16 UTC

Ganhos

Salesforce CEO: Williams-Sonoma's Agentforce Makes Up 60% of Customer Chats

3 de dez. de 2025, 22:15 UTC

Ganhos

Salesforce CEO: Agentforce ARR Was $540M in 3Q

3 de dez. de 2025, 22:10 UTC

Aquisições, Fusões, Aquisições de Empresas

EQB: Will Enter Into a Long-Term Strategic Relationship With Loblaw >EQB.T

3 de dez. de 2025, 22:09 UTC

Aquisições, Fusões, Aquisições de Empresas

EQB: Agreed to Acquire PC Fincl From Loblaw >EQB.T

3 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

3 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

3 de dez. de 2025, 21:49 UTC

Ganhos

Salesforce Reports Mounting Profits. The Stock Is Rising. -- Barrons.com

3 de dez. de 2025, 21:23 UTC

Ganhos

Salesforce Raises Revenue Forecast as Agentforce Sales Top $500M

3 de dez. de 2025, 21:19 UTC

Ganhos

Salesforce Reports Mounting Profits. The Stock Is Rising. -- Barrons.com

3 de dez. de 2025, 21:06 UTC

Ganhos

Salesforce Reports Mixed Earnings. The Stock Is Rising. -- Barrons.com

3 de dez. de 2025, 21:04 UTC

Ganhos

Salesforce Sees Profitable Growth Framework Target of 50 by FY30 >CRM

3 de dez. de 2025, 21:04 UTC

Ganhos

Salesforce Targets $60 B Plus Organic Rev by FY30 >CRM

3 de dez. de 2025, 21:03 UTC

Ganhos

Salesforce Raises FY26 Oper Cash Flow Growth Guidance to 13% to 14% Y/Y >CRM

Comparação entre Pares

Variação de preço

Stevanato Group SpA Previsão

Preço-alvo

By TipRanks

22.17% parte superior

Previsão para 12 meses

Média 27 USD  22.17%

Máximo 30 USD

Mínimo 24 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Stevanato Group SpA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

2

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

21.56 / 22.61Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

167 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat